Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of selective digestive decontamination on the pangenome composition of ESBL-E. coli.

The Journal of antimicrobial chemotherapy·2026
Same author

Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practice.

BMJ oncology·2026
Same author

Phenotypic convergence and collateral susceptibility development in Pseudomonas aeruginosa under antibiotic exposure in ICU patients.

npj antimicrobials and resistance·2026
Same author

Serotype distribution and coverage by pneumococcal vaccines in hospitalised adults with pneumococcal pneumonia in Germany.

ERJ open research·2026
Same author

Failure to rescue the trial: lessons from a randomised antibiotic treatment trial in the acute care setting.

Trials·2026
Same author

Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases.

Contemporary clinical trials communications·2026

Related Experiment Video

Updated: Jun 26, 2026

A Tactile Automated Passive-Finger Stimulator (TAPS)
19:44

A Tactile Automated Passive-Finger Stimulator (TAPS)

Published on: June 3, 2009

Modelling treatment effects in a clinical Bayesian network using Boolean threshold functions.

Stefan Visscher1, Peter J F Lucas, Carolina A M Schurink

  • 1Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, The Netherlands. Stefan.Visscher@gmail.com

Artificial Intelligence in Medicine
|December 30, 2008
PubMed
Summary
This summary is machine-generated.

Timely antimicrobial treatment is crucial for critically ill patients. Bayesian networks with specific noisy-threshold models can improve ventilator-associated pneumonia (VAP) diagnosis and treatment decisions.

Related Experiment Videos

Last Updated: Jun 26, 2026

A Tactile Automated Passive-Finger Stimulator (TAPS)
19:44

A Tactile Automated Passive-Finger Stimulator (TAPS)

Published on: June 3, 2009

Area of Science:

  • Medical Informatics
  • Computational Biology
  • Infectious Diseases

Background:

  • Prompt antimicrobial treatment is vital for critically ill patients to improve outcomes.
  • Ventilator-associated pneumonia (VAP) is a common intensive care unit (ICU) infection, difficult to diagnose clinically.
  • Computer-based decision support systems may aid in VAP diagnosis and management.

Purpose of the Study:

  • To develop and evaluate a Bayesian network-based decision support system for VAP.
  • To model the complex interactions between pathogens, antibiotic usage, and treatment effectiveness.
  • To investigate the utility of different causal independence models, including noisy-threshold models, for VAP management.

Main Methods:

  • Utilized a Bayesian network to model uncertainty in VAP diagnosis and treatment.
  • Modeled the impact of antibiotic usage on respiratory tract colonization by pathogens.
  • Investigated noisy-AND and generalized noisy-threshold models for pathogen coverage by antibiotics, tested on ICU patient data.

Main Results:

  • Certain constructed noisy-threshold models enhanced the Bayesian network's performance.
  • These models improved the system's ability to identify causative pathogens and suggest appropriate antimicrobial treatment.
  • The study demonstrated potential improvements in VAP management through refined modeling.

Conclusions:

  • Refining Bayesian network interactions using causal independence theory can improve performance.
  • Specific noisy-threshold models are suitable for modeling pathogen-antimicrobial interactions in VAP.
  • Noisy-OR and noisy-AND models may not always be optimal for modeling complex biological interactions.